Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Honegger

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Investigation|January 7, 2020
CD4+ T cell restoration and control of hepatitis C virus replication after childbirthSamantha L Coss, Almudena Torres-Cornejo, Mona R Prasad, et al.
Inflammatory Bowel Diseases|July 21, 2010
Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case seriesJennifer L Dotson, Wallace Crandall, Hayat Mousa, et al.
The Journal of Pediatrics|July 26, 2018
Clinical and Radiologic Manifestations of Bone Infection in Children with Cat Scratch DiseaseGuliz Erdem, Joshua R Watson, W Garrett Hunt, et al.
Nature Medicine|October 29, 2013
Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted virusesJonathan R Honegger, Seungtaek Kim, Aryn A Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recoveryJonathan R Honegger, Dana Tedesco, Jennifer A Kohout, et al.
Pediatric Pulmonology|November 12, 2025
Breaking the Mold! A Rare Lung Neoplasm in ChildhoodEric S Mull, Rachel Gaudio, Brent Adler, et al.
JCI Insight|September 24, 2024
T cell responses and clinical symptoms among infants with congenital cytomegalovirus infectionAlexandra K Medoro, Ravi Dhital, Pablo J Sánchez, et al.
The Lancet. Child & Adolescent Health|March 20, 2025
Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry studyRegino P Gonzalez-Peralta, Jessica W Wen, Winita Hardikar, et al.
Hepatology (Baltimore, Md.)|June 21, 2019
Ledipasvir-Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis CKathleen B Schwarz, Philip Rosenthal, Karen F Murray, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2020
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variantRoshini S Abraham, Joanna M Marshall, Hye Sun Kuehn, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Investigation|January 7, 2020
CD4+ T cell restoration and control of hepatitis C virus replication after childbirthSamantha L Coss, Almudena Torres-Cornejo, Mona R Prasad, et al.
Inflammatory Bowel Diseases|July 21, 2010
Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case seriesJennifer L Dotson, Wallace Crandall, Hayat Mousa, et al.
The Journal of Pediatrics|July 26, 2018
Clinical and Radiologic Manifestations of Bone Infection in Children with Cat Scratch DiseaseGuliz Erdem, Joshua R Watson, W Garrett Hunt, et al.
Nature Medicine|October 29, 2013
Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted virusesJonathan R Honegger, Seungtaek Kim, Aryn A Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recoveryJonathan R Honegger, Dana Tedesco, Jennifer A Kohout, et al.
Pediatric Pulmonology|November 12, 2025
Breaking the Mold! A Rare Lung Neoplasm in ChildhoodEric S Mull, Rachel Gaudio, Brent Adler, et al.
JCI Insight|September 24, 2024
T cell responses and clinical symptoms among infants with congenital cytomegalovirus infectionAlexandra K Medoro, Ravi Dhital, Pablo J Sánchez, et al.
The Lancet. Child & Adolescent Health|March 20, 2025
Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry studyRegino P Gonzalez-Peralta, Jessica W Wen, Winita Hardikar, et al.
Hepatology (Baltimore, Md.)|June 21, 2019
Ledipasvir-Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis CKathleen B Schwarz, Philip Rosenthal, Karen F Murray, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2020
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variantRoshini S Abraham, Joanna M Marshall, Hye Sun Kuehn, et al.
Pageof 2